Stay updated on Intratumoral IMO-2125 in Refractory Solid Tumors Clinical Trial

Sign up to get notified when there's something new on the Intratumoral IMO-2125 in Refractory Solid Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Intratumoral IMO-2125 in Refractory Solid Tumors Clinical Trial page

  1. Check
    today
    Change Detected
    Summary
    The footer revision identifier changed from v3.7.2 to v3.8.0; the page content remains a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-31T13:09:18.000Z thumbnail image
  2. Check
    7 days ago
    Change Detected
    Summary
    A site-wide banner announces NIH website transition updates and says some NIH content may use “Super Intelligence” instead of “Artificial Intelligence”.
    Difference
    1%
    Check dated 2026-10-24T16:27:31.000Z thumbnail image
  3. Check
    14 days ago
    Change Detected
    Summary
    The site revision identifier in the footer changed from v3.7.1 to v3.7.2.
    Difference
    0.2%
    Check dated 2026-10-17T16:14:05.000Z thumbnail image
  4. Check
    21 days ago
    Change Detected
    Summary
    The footer revision identifier changed from v3.7.0 to v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-10T16:07:43.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error, replacing the study record view for this NCT entry. This indicates the content is not accessible at this URL.
    Difference
    17%
    Check dated 2026-09-19T22:03:03.000Z thumbnail image
  6. Check
    63 days ago
    Change Detected
    Summary
    The page now shows revision v3.6.6, replacing the prior v3.6.5. This indicates a minor update to the page content rather than a change to the study data or functionality.
    Difference
    0.1%
    Check dated 2026-08-29T19:16:18.000Z thumbnail image

Stay in the know with updates to Intratumoral IMO-2125 in Refractory Solid Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Intratumoral IMO-2125 in Refractory Solid Tumors Clinical Trial page.